InvestorsHub Logo
Followers 13
Posts 847
Boards Moderated 0
Alias Born 01/29/2013

Re: None

Thursday, 01/11/2018 7:43:49 PM

Thursday, January 11, 2018 7:43:49 PM

Post# of 403771
I believe each new partnership will be worth a $3-$5 increase in price per share. Final FDA approval will be worth a minimum of $6 - $10 per share per drug. At that point one of the partners will consider a buyout at a premium. Their BOD will have no problem paying up for a new pipeline.